The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Galectin-9 expression and decreased survival in advanced biliary tract cancers.
 
Jessica M. Keilson
No Relationships to Disclose
 
Amanda Ruggieri
No Relationships to Disclose
 
Jacklyn Hammons
No Relationships to Disclose
 
Helen X. Chen
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Mark Yarchoan
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Genentech/Roche; Geneos
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Merck
 
Nilofer Saba Azad
Consulting or Advisory Role - AMAG Pharmaceuticals; Helsinn Therapeutics/QED Therapeutics; Incyte; Merck; QED Therapeutics; Taiho Pharmaceutical
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); AtlasMedx (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); EMD Serono; Genentech (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Syndax (Inst)
 
Caroline Medin
No Relationships to Disclose
 
Curtis Henry
Research Funding - PureTech
 
Brian Robinson
No Relationships to Disclose
 
Shishir K. Maithel
Research Funding - Celgene
 
Gregory B. Lesinski
Consulting or Advisory Role - ProDa
Research Funding - Boehringer Ingelheim (Inst); Bristol Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Vaccinex (Inst)